Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

C Ferri, F Ursini, L Gragnani, V Raimondo… - Journal of …, 2021 - Elsevier
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

[引用][C] Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

C Ferri, F Ursini, L Gragnani, V Raimondo… - Journal of …, 2021 - cir.nii.ac.jp
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High
prevalence of non-response in different patients’ subgroups | CiNii Research CiNii 国立情報学 …

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

C Ferri, F Ursini, L Gragnani, V Raimondo… - JOURNAL OF …, 2021 - iris.unicampania.it
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

C Ferri, F Ursini, L Gragnani, V Raimondo… - JOURNAL OF …, 2021 - publicatt.unicatt.it
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

[HTML][HTML] Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

C Ferri, F Ursini, L Gragnani, V Raimondo… - Journal of …, 2021 - ncbi.nlm.nih.gov
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

C Ferri, F Ursini, L Gragnani… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

C Ferri, F Ursini, L Gragnani, V Raimondo… - JOURNAL OF …, 2021 - arpi.unipi.it
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

C Ferri, F Ursini, L Gragnani, V Raimondo… - JOURNAL OF …, 2021 - cris.unibo.it
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

C Ferri, F Ursini, L Gragnani, V Raimondo… - JOURNAL OF …, 2021 - iris.unimore.it
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.

C Ferri, F Ursini, L Gragnani, V Raimondo… - Journal of …, 2021 - europepmc.org
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …